INS and type 2 diabetes mellitus: Several works have demonstrated that in people with type 2 diabetes (T2D), the mechanisms that control the incretin effect are defective, leading to impaired regulation of insulin and glucagon secretion and exaggerated plasma glucose excursions after meals [9,10].